Literature DB >> 21118682

Gambogenic acid mediated apoptosis through the mitochondrial oxidative stress and inactivation of Akt signaling pathway in human nasopharyngeal carcinoma CNE-1 cells.

Fenggen Yan1, Mei Wang, Hui Chen, Jingjing Su, Xiaoshan Wang, Fei Wang, Lunzhu Xia, Qinglin Li.   

Abstract

In the present study, Gambogenic acid exhibits potential anti-tumor activity in several cancer cell lines. However, Gambogenic acid-induced apoptosis mechanism is not well understood. Here, we report that Gambogenic acid was capable to induce CNE-1 cells apoptosis and caused mitochondrial and endoplasmic reticulum injury, analyzed via transmission electron microscopy and acridine orange/ethidium bromide (AO/EB) double staining. To quantitatively analyze apoptosis, through the propidium iodide (PI)/Annexin V-FITC double staining to detect cell apoptosis, PI staining of the cell cycle distribution. To further explore the potential mechanism of Gambogenic acid mediated apoptosis in CNE-1 cells, we also examined mitochondrial oxidative stress in the levels of reactive oxygen species, the release of cytochrome c, intracellular Ca(2+) concentration and mitochondrial membrane potential by flow cytometry. Moreover, Gambogenic acid could result in a time and concentration-dependent decrease in Phospho-Akt expression, basal expression levels of Akt change was not obvious, In addition, we detected Bcl-2 family including Bcl-2, Bax and Bad expression in mRNA level. This resulted in a decrease of Bcl-2 and Bad increased in CNE-1 cells after Gambogenic acid treatment. Overall, our results indicated that Gambogenic acid mediated apoptosis through inactivation of Akt, accompanied with mitochondrial oxidative stress and cross-talk with Bcl-2 family in the process of apoptosis. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21118682     DOI: 10.1016/j.ejphar.2010.11.018

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  Apoptosis induced by ZnPcH1-based photodynamic therapy in Jurkat cells and HEL cells.

Authors:  Huifang Huang; Xiaoyan Zhao; Yuanzhong Chen; Rong Lu; Yong Wu
Journal:  Int J Hematol       Date:  2011-11-17       Impact factor: 2.490

Review 2.  Targeting the unfolded protein response in head and neck and oral cavity cancers.

Authors:  Daniel W Cole; Peter F Svider; Kerolos G Shenouda; Paul B Lee; Nicholas G Yoo; Thomas M McLeod; Sean A Mutchnick; George H Yoo; Randal J Kaufman; Michael U Callaghan; Andrew M Fribley
Journal:  Exp Cell Res       Date:  2019-05-07       Impact factor: 3.905

3.  Effect of Gambogenic Acid on Cytochrome P450 1A2, 2B1 and 2E1, and Constitutive Androstane Receptor in Rats.

Authors:  Jing Sun; Xiaozhu Tang; Qianqian Xu; Tao Ge; Daiyin Peng; Weidong Chen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-12       Impact factor: 2.441

4.  Gambogenic acid inhibits LPS-simulated inflammatory response by suppressing NF-κB and MAPK in macrophages.

Authors:  Xianjun Yu; Qun Zhao; Haiwei Zhang; Cunxian Fan; Xixi Zhang; Qun Xie; Chengxian Xu; Yongbo Liu; Xiaoxia Wu; Quanbin Han; Haibing Zhang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-03-29       Impact factor: 3.848

5.  Neuroprotective Effects of Etidronate and 2,3,3-Trisphosphonate Against Glutamate-Induced Toxicity in PC12 Cells.

Authors:  Wen Li; Yuen-Ki Cheong; Hui Wang; Guogang Ren; Zhuo Yang
Journal:  Neurochem Res       Date:  2015-11-11       Impact factor: 3.996

6.  Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin.

Authors:  Ye He; Jie Ding; Yan Lin; Juan Li; Yongguo Shi; Juan Wang; Ya Zhu; Keming Wang; Xuezhen Hu
Journal:  BMC Complement Altern Med       Date:  2015-06-12       Impact factor: 3.659

7.  Enhancement of radiotherapy by ceria nanoparticles modified with neogambogic acid in breast cancer cells.

Authors:  Feng Chen; Xiao Hong Zhang; Xiao Dan Hu; Wei Zhang; Zhi Chao Lou; Li Hua Xie; Pei Dang Liu; Hai Qian Zhang
Journal:  Int J Nanomedicine       Date:  2015-08-14

8.  A covalently bound inhibitor triggers EZH2 degradation through CHIP-mediated ubiquitination.

Authors:  Xu Wang; Wei Cao; Jianjun Zhang; Ming Yan; Qin Xu; Xiangbing Wu; Lixin Wan; Zhiyuan Zhang; Chenping Zhang; Xing Qin; Meng Xiao; Dongxia Ye; Yuyang Liu; Zeguang Han; Shaomeng Wang; Li Mao; Wenyi Wei; Wantao Chen
Journal:  EMBO J       Date:  2017-03-20       Impact factor: 11.598

9.  Gambogenic acid kills lung cancer cells through aberrant autophagy.

Authors:  Wang Mei; Chen Dong; Cheng Hui; Li Bin; Yan Fenggen; Su Jingjing; Peng Cheng; Sun Meiling; Hu Yawen; Wang Xiaoshan; Wang Guanghui; Chen Zhiwu; Li Qinglin
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

10.  Contribution of reactive oxygen species to the anticancer activity of aminoalkanol derivatives of xanthone.

Authors:  Daniel Sypniewski; Natalia Szkaradek; Tomasz Loch; Anna M Waszkielewicz; Agnieszka Gunia-Krzyżak; Daria Matczyńska; Dagna Sołtysik; Henryk Marona; Ilona Bednarek
Journal:  Invest New Drugs       Date:  2017-11-08       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.